Patented light-activated Photo Dynamic Compounds ("PDCs") have been scientifically and preclinically researched for 18+ years to optimize their ability to destroy cancer, bacteria and viruses.
Over 10+ peer reviewed published research publications.
Data last updated on June 27, 2022
- TSX Venture Exchange (TSXV: TLT)
- Over-The-Counter Exchange (OTCQB: TLTFF)
Share Price: C$0.345
Market Capital: $CAN 70.9 M
Shares Outstanding: 204,425,875
Stock Options: 10,440,000
For Investor Relations please contact: Investor Information Theralase®